Status:
COMPLETED
BIS Monitoring in Relation to Muscle Relaxant Administration
Lead Sponsor:
Mayo Clinic
Conditions:
Cardiovascular Surgery
Bispectral Index
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.
Eligibility Criteria
Inclusion
- Undergoing elective cardiac surgery
- Muscle relaxation administration by rocuronium
Exclusion
- Patient refusal
- Pediatric patients
- Emergency procedure
- Patients with known or suspected carotid or cerebrovascular disease
- Patients with prior stroke
- Skin condition or anatomy preventing proper sensor placement
- Patients who receive ketamine during the study timeframe
Key Trial Info
Start Date :
August 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05440058
Start Date
August 26 2022
End Date
September 20 2022
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905